Vergote I, Van Nieuwenhuysen E, O'Cearbhaill RE, Westermann A, et al. Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study. J Clin Oncol 2023 Aug 31:JCO2300720. doi: 10.1200/JCO.23.00720.
PMID: 37651655